Inheris_High_Resolution.jpg

A wholly owned subsidiary of Nektar

JayGaleota new bg.pngJay Galeota
President & Chief Executive Officer

Jay Galeota brings more than three decades of industry experience to Inheris, including a 28-year tenure at Merck & Co., where he held several leadership roles where he held leadership roles in commercial operations, business development, and corporate strategy. Most recently, Mr. Galeota served as President of G&W Laboratories, a fully-integrated specialty pharmaceutical company, overseeing all business operations including research and development, commercial, manufacturing, business development and supply chain. While at Merck & Co., Mr. Galeota served as Chief Strategy & Business Development Officer, and President, Emerging Businesses at Merck where he led the development and execution of the company’s corporate strategy, led Merck’s Corporate Business Development & Licensing area, oversaw corporate business development and licensing, and spearheaded creative solutions to enable growth outside of Merck’s core, investment and resourcing strategies. Prior to that, Mr. Galeota was the president of Merck’s Hospital and Specialty Care division, responsible for more than $10 billion in worldwide revenue.

Mr. Galeota holds a B.S. in Biology from Villanova University and is a graduate of Harvard Business School’s Advanced Management Program.